Esch sur AlzetteLuxembourgEuropeAn tiparkinson AgentsBasal Ganglia Diseases and ConditionsBrain Diseases and Co nditionsCentral Nervous System AgentsCentral Nervous System Diseases and Con ditionsCyborgsDihydroxyphenylalanineDopaminergic Antiparkinsonism AgentsDrugs and TherapiesDyskinesiasEmerging TechnologiesHealth and MedicineLe vodopaLevodopa TherapyMachine LearningMovement DisordersMusculoskeletal Diseases and ConditionsNervous System Diseases and ConditionsNeurodegenerati ve Diseases and ConditionsNeurologyParkinson’s DiseaseParkinsonian Disorde rsPharmaceuticalsRisk and Prevention
2024